Vaishali Pharma Limited Total Liabilities
Vaishali Pharma Limited total liabilities. Based on the latest financial reports, Vaishali Pharma Limited (VAISHALI) has total liabilities worth Rs-691.15 Million INR (≈ $-7.47 Million USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Vaishali Pharma Limited asset resilience ratio to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Vaishali Pharma Limited (2013–2026)
Total liabilities of Vaishali Pharma Limited from 2013 to 2026. This chart illustrates how Vaishali Pharma Limited's total liabilities have evolved over time, based on quarterly financial data.
Vaishali Pharma Limited Competitors by Total Liabilities
The table below lists competitors of Vaishali Pharma Limited ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
ESSA Pharma Inc
NASDAQ:EPIX
|
USA | $1.60 Million |
|
Investcorp Credit Management BDC Inc
NASDAQ:ICMB
|
USA | $111.71 Million |
|
VL E-Governance & IT Solutions Limited
NSE:VLEGOV
|
India | Rs-456.97 Million |
|
Tian An Australia Ltd
AU:TIA
|
Australia | AU$188.16 Million |
|
Mainz Biomed BV
NASDAQ:MYNZ
|
USA | $4.69 Million |
|
Intanwijaya Internasional Tbk
JK:INCI
|
Indonesia | Rp73.38 Billion |
|
Cuscapi Berhad
KLSE:0051
|
Malaysia | RM21.42 Million |
|
Nala Digital Commerce Ltd
TA:NALA
|
Israel | ILA1.38 Million |
Liability Composition Analysis (2013–2026)
This chart breaks down Vaishali Pharma Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Vaishali Pharma Limited balance sheet assets.
Liquidity & Leverage Metrics
Vaishali Pharma Limited Total Liabilities Ratios Explained
Vaishali Pharma Limited total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | N/A | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | -1.00 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | N/A | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Vaishali Pharma Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Vaishali Pharma Limited (2013–2026)
The table below shows the annual total liabilities of Vaishali Pharma Limited from 2013 to 2026.
| Year | Total Liabilities | Change |
|---|---|---|
| 2026-03-31 | Rs542.74 Million ≈ $5.87 Million |
+20.80% |
| 2025-03-31 | Rs449.29 Million ≈ $4.86 Million |
+21.05% |
| 2024-03-31 | Rs371.16 Million ≈ $4.01 Million |
-3.28% |
| 2023-03-31 | Rs383.76 Million ≈ $4.15 Million |
-30.57% |
| 2022-03-31 | Rs552.70 Million ≈ $5.98 Million |
-13.24% |
| 2021-03-31 | Rs637.05 Million ≈ $6.89 Million |
+42.13% |
| 2020-03-31 | Rs448.23 Million ≈ $4.85 Million |
-5.34% |
| 2019-03-31 | Rs473.52 Million ≈ $5.12 Million |
+8.30% |
| 2018-03-31 | Rs437.22 Million ≈ $4.73 Million |
+7.21% |
| 2017-03-31 | Rs407.80 Million ≈ $4.41 Million |
-12.34% |
| 2016-03-31 | Rs465.19 Million ≈ $5.03 Million |
+9.30% |
| 2015-03-31 | Rs425.60 Million ≈ $4.60 Million |
-15.48% |
| 2014-03-31 | Rs503.56 Million ≈ $5.45 Million |
+9.93% |
| 2013-03-31 | Rs458.09 Million ≈ $4.95 Million |
-- |
About Vaishali Pharma Limited
Vaishali Pharma Limited engages in the pharmaceutical business in India and internationally. It offers a portfolio of active pharmaceutical ingredients, such as antibiotics, anti-ulcer, anti-inflammatory, analgesic, anti-pyretic, topical steroids, anti"malarial, cardiac, corticosteroids, anti-diabetics, anti-cold, anti-allergic, anti-diarrheal, anti-protozoal, anti-parasitic, excipients, anti-vir… Read more